Yiwen Li

1.4k total citations · 1 hit paper
18 papers, 1.1k citations indexed

About

Yiwen Li is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Yiwen Li has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in Yiwen Li's work include Cardiac Fibrosis and Remodeling (5 papers), Signaling Pathways in Disease (4 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Yiwen Li is often cited by papers focused on Cardiac Fibrosis and Remodeling (5 papers), Signaling Pathways in Disease (4 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Yiwen Li collaborates with scholars based in Japan, China and United States. Yiwen Li's co-authors include Genzou Takemura, Rumi Maruyama, Hisayoshi Fujiwara, Shinya Minatoguchi, Takako Fujiwara, Hideshi Okada, Yanfei Liu, Wenting Wang, Shiwei Liu and Mengqi Gao and has published in prestigious journals such as Circulation, Molecules and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Yiwen Li

17 papers receiving 1.0k citations

Hit Papers

Diabetic vascular diseases: molecular mechanisms and ther... 2023 2026 2024 2025 2023 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiwen Li Japan 12 455 412 197 124 117 18 1.1k
Aimilia Varela Greece 16 284 0.6× 483 1.2× 131 0.7× 127 1.0× 157 1.3× 33 902
Kazutaka Ueda Japan 16 327 0.7× 291 0.7× 156 0.8× 85 0.7× 155 1.3× 48 891
Tieqiang Zhao United States 20 477 1.0× 455 1.1× 203 1.0× 118 1.0× 118 1.0× 35 1.1k
Masakatsu Wakeno Japan 13 409 0.9× 436 1.1× 146 0.7× 97 0.8× 116 1.0× 13 1.0k
Abhijit Takawale Canada 19 749 1.6× 579 1.4× 334 1.7× 217 1.8× 148 1.3× 26 1.5k
Robert Scheubel Germany 14 309 0.7× 544 1.3× 216 1.1× 148 1.2× 106 0.9× 29 1.1k
Navid Koleini Canada 13 397 0.9× 373 0.9× 76 0.4× 151 1.2× 74 0.6× 30 1.0k
Youchun Jiang United States 10 328 0.7× 371 0.9× 120 0.6× 60 0.5× 104 0.9× 10 942
Doubun Hayashi Japan 17 645 1.4× 886 2.2× 258 1.3× 102 0.8× 108 0.9× 29 1.4k
Wei-Jan Chen Taiwan 25 631 1.4× 581 1.4× 179 0.9× 97 0.8× 349 3.0× 55 1.7k

Countries citing papers authored by Yiwen Li

Since Specialization
Citations

This map shows the geographic impact of Yiwen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiwen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiwen Li more than expected).

Fields of papers citing papers by Yiwen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiwen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiwen Li. The network helps show where Yiwen Li may publish in the future.

Co-authorship network of co-authors of Yiwen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yiwen Li. A scholar is included among the top collaborators of Yiwen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiwen Li. Yiwen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
He, Y., et al.. (2025). Application of Traditional Chinese Medicine in Alzheimer’s Disease Treatment: A Focus on the Wnt/β-Catenin Pathway. The American Journal of Chinese Medicine. 53(6). 1641–1683.
3.
Wang, Wenting, Yanfei Liu, Qian Xu, et al.. (2025). Cellular crosstalk in organotypic vasculature: mechanisms of diabetic cardiorenal complications and SGLT2i responses. Cardiovascular Diabetology. 24(1). 90–90. 3 indexed citations
4.
Li, Yiwen, Yanfei Liu, Shiwei Liu, et al.. (2023). Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduction and Targeted Therapy. 8(1). 152–152. 337 indexed citations breakdown →
6.
Chen, Jin, Yue Zhang, Xiao Hu, et al.. (2022). Comparison of efficacy of roxadustat and erythropoietin for the treatment of renal anemia in patients with chronic kidney disease: a retrospective study. Translational Andrology and Urology. 11(11). 1568–1576. 6 indexed citations
7.
Guan, Ziqiang, Yiwen Li, Shuliang Jiao, et al.. (2020). A2E Distribution in RPE Granules in Human Eyes. Molecules. 25(6). 1413–1413. 10 indexed citations
8.
Aziz, Qadeer, Yiwen Li, & Andrew Tinker. (2018). Potassium channels in the sinoatrial node and their role in heart rate control. Channels. 12(1). 356–366. 20 indexed citations
9.
Hung, Dong‐Zong, et al.. (2016). Association between antiepileptic drugs and hepatocellular carcinoma in patients with epilepsy: a population‐based case–control study. Brain and Behavior. 6(11). e00554–e00554. 3 indexed citations
10.
Kanamori, Hiromitsu, Genzou Takemura, Yiwen Li, et al.. (2007). Inhibition of Fas-associated apoptosis in granulation tissue cells accompanies attenuation of postinfarction left ventricular remodeling by olmesartan. American Journal of Physiology-Heart and Circulatory Physiology. 292(5). H2184–H2194. 26 indexed citations
11.
Li, Yiwen, Genzou Takemura, Hideshi Okada, et al.. (2006). ANG II type 1A receptor signaling causes unfavorable scar dynamics in the postinfarct heart. American Journal of Physiology-Heart and Circulatory Physiology. 292(2). H946–H953. 12 indexed citations
12.
Koda, Masahiko, Genzou Takemura, Hideshi Okada, et al.. (2006). Nuclear Hypertrophy Reflects Increased Biosynthetic Activities in Myocytes of Human Hypertrophic Hearts. Circulation Journal. 70(6). 710–718. 33 indexed citations
13.
Li, Longhu, Genzou Takemura, Yiwen Li, et al.. (2006). Preventive Effect of Erythropoietin on Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy. Circulation. 113(4). 535–543. 174 indexed citations
14.
Li, Yiwen, Genzou Takemura, Hideshi Okada, et al.. (2005). Treatment with granulocyte colony-stimulating factor ameliorates chronic heart failure. Laboratory Investigation. 86(1). 32–44. 47 indexed citations
15.
Okada, Hideshi, Genzou Takemura, Ken-ichiro Kosai, et al.. (2005). Postinfarction Gene Therapy Against Transforming Growth Factor-β Signal Modulates Infarct Tissue Dynamics and Attenuates Left Ventricular Remodeling and Heart Failure. Circulation. 111(19). 2430–2437. 156 indexed citations
16.
Koda, Masahiko, Genzou Takemura, Motoo Kanoh, et al.. (2003). Myocytes positive for in situ markers for DNA breaks in human hearts which are hypertrophic, but neither failed nor dilated: a manifestation of cardiac hypertrophy rather than failure. The Journal of Pathology. 199(2). 229–236. 32 indexed citations
17.
Hayakawa, Kenji, Genzou Takemura, Motoo Kanoh, et al.. (2003). Inhibition of Granulation Tissue Cell Apoptosis During the Subacute Stage of Myocardial Infarction Improves Cardiac Remodeling and Dysfunction at the Chronic Stage. Circulation. 108(1). 104–109. 93 indexed citations
18.
Li, Yiwen, Genzou Takemura, Ken-ichiro Kosai, et al.. (2003). Postinfarction Treatment With an Adenoviral Vector Expressing Hepatocyte Growth Factor Relieves Chronic Left Ventricular Remodeling and Dysfunction in Mice. Circulation. 107(19). 2499–2506. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026